Oxidation for Health…Physical and Fiscal[Ed. Note: Dr. KSS writes about medical topics and biotech stocks for the Irregulars. He has agreed to our trading restrictions, and his thoughts and words are his own. Enjoy!] Here we are, solidly in the postmodern 21st century, “so late in the goddam day,” as one of novelist Martin Amis’s characters says, and what […]
Articles
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More Info
Comments
$CLRB wow > Cellectar and Orano Med Announce Collaboration to Develop New Phospholipid Drug Conjugate http://investor...
$CLRB Filed Form S-1MEFFiling Date Jul 26, 2018 Document Date Jul 26, 2018 Form Description Registration of up to an a...
$CLRB wow > Cellectar Announces Expansion of Diffuse Large B-Cell Lymphoma Cohort in CLR 131 Phase 2 Trial http://in...
$CLRB wow - Cellectar Presents Preclinical Data at AACR Annual Meeting Demonstrating the Ability of its PDCs to Selectiv...
CLRB will rise again and rise far beyond its former stature....indeed it's doing that now. I am having an extended meeti...
$CLRB FP http://ih.advfn.com/p.php?pid=nmona&article=76297281&adw=1126416...